Abstract:
This invention relates to, among other embodiments, methods and apparatus/systems for controlling gases delivery to a patient, such as via a patient interface. Such methods comprising receiving an input relating to either a patient's breathing phase and/or another patient parameter, controlling a flow of gases to be delivered to the patient and the inclusion in said flow of gases of a supplementary gas, wherein the amount of supplementary gas provided to the patient is substantially synchronized with respect to the patient's breathing phase and/or another patient parameter.
Abstract:
An oxygen concentrator comprises a product tank that is fluidly coupled to at least one sieve bed, and a product gas accumulator tank that is fluidly coupled to the product tank via a first conduit and to an outlet port via a second conduit, wherein the first conduit and the second conduit are disposed to allow at least a portion of product gas to flow from the product tank to the outlet port through the accumulator tank.
Abstract:
An HME device, used in a closed breathing circuit of a ventilation system, has a housing with an inlet opening and with an outlet opening, an HME chamber (50a; 50b; 50c; 50d; 50e; 50f; 50g; 50h; 50i) arranged between the inlet opening and the outlet opening for receiving an HME medium and a switching mechanism (70a; 70b; 70c; 70d; 70e; 70f; 70g; 70h; 70i). The HME device can be switched over between an HME mode (M1), in which an HME fluid passage is provided from the inlet opening through the HME chamber to the outlet opening, and a bypass mode (M2), in which a fluid bypass passage is provided from the inlet opening past the HME chamber through a bypass channel (80a; 80b; 80d; 80e; 80f; 80h) in the housing to the outlet opening. The bypass channel is blocked with respect to the HME chamber in the bypass mode (M2).
Abstract:
A breathable gas inlet control device permits flow regulation at the inlet of a flow generator for a respiratory treatment apparatus such as a ventilator or continuous positive airway pressure device. The device may implement a variable inlet aperture size based on flow conditions. In one embodiment, an inlet flow seal opens or closes the inlet to a blower in accordance with changes in pressure within a seal activation chamber near the seal. The seal may be formed by a flexible membrane. A controller selectively changes the pressure of the seal activation chamber by controlling a set of one or more flow control valves to selectively stop forward flow, prevent back flow or lock open the seal to permit either back flow or forward flow. The controller may set the flow control valves as a function of detected respiratory conditions based on data from pressure and/or flow sensors.
Abstract:
Described are systems and methods for compensating long term sensitivity drift of catalytic type electrochemical gas sensors used in systems for delivering therapeutic nitric oxide (NO) gas to a patient by compensating for drift that may be specific to the sensors atypical use in systems for delivering therapeutic nitric oxide gas to a patient. In at least some instances, the long term sensitivity drift of catalytic type electrochemical gas sensors can be addressed using calibration schedules, which can factor in the absolute change in set dose of NO being delivered to the patient that can drive one or more baseline calibrations. The calibration schedules can be used reduce the amount of times the sensor goes offline. Systems and methods described may factor in in actions occurring at the delivery system and/or aspects of the surrounding environment, prior to performing a baseline calibration, and may postpone the calibration and/or rejected using the sensor's output for the calibration.
Abstract:
Described are systems and methods for compensating long term sensitivity drift of catalytic type electrochemical gas sensors used in systems for delivering therapeutic nitric oxide (NO) gas to a patient by compensating for drift that may be specific to the sensors atypical use in systems for delivering therapeutic nitric oxide gas to a patient. In at least some instances, the long term sensitivity drift of catalytic type electrochemical gas sensors can be addressed using calibration schedules, which can factor in the absolute change in set dose of NO being delivered to the patient that can drive one or more baseline calibrations. The calibration schedules can be used reduce the amount of times the sensor goes offline. Systems and methods described may factor in in actions occurring at the delivery system and/or aspects of the surrounding environment, prior to performing a baseline calibration, and may postpone the calibration and/or rejected using the sensor's output for the calibration.
Abstract:
Described are systems and methods for compensating long term sensitivity drift of catalytic type electrochemical gas sensors used in systems for delivering therapeutic nitric oxide (NO) gas to a patient by compensating for drift that may be specific to the sensors atypical use in systems for delivering therapeutic nitric oxide gas to a patient. In at least some instances, the long term sensitivity drift of catalytic type electrochemical gas sensors can be addressed using calibration schedules, which can factor in the absolute change in set dose of NO being delivered to the patient that can drive one or more baseline calibrations. The calibration schedules can be used reduce the amount of times the sensor goes offline. Systems and methods described may factor in in actions occurring at the delivery system and/or aspects of the surrounding environment, prior to performing a baseline calibration, and may postpone the calibration and/or rejected using the sensor's output for the calibration.
Abstract:
Systems and methods for classifying breathing disorders of subjects are based on the respiratory response to a change in a pressure level of a pressurized flow of breathable gas. The change presents a breathing challenge to a subject. The challenge may be limited to the inspiratory breathing phase. The inspiratory pressure level may be lower than the expiratory pressure level during challenges.
Abstract:
Described are systems and methods for compensating long term sensitivity drift of catalytic type electrochemical gas sensors used in systems for delivering therapeutic nitric oxide (NO) gas to a patient by compensating for drift that may be specific to the sensors atypical use in systems for delivering therapeutic nitric oxide gas to a patient. In at least some instances, the long term sensitivity drift of catalytic type electrochemical gas sensors can be addressed using calibration schedules, which can factor in the absolute change in set dose of NO being delivered to the patient that can drive one or more baseline calibrations. The calibration schedules can be used reduce the amount of times the sensor goes offline. Systems and methods described may factor in in actions occurring at the delivery system and/or aspects of the surrounding environment, prior to performing a baseline calibration, and may postpone the calibration and/or rejected using the sensor's output for the calibration.
Abstract:
A flowmeter comprises a lower valve body (1), a throttle assembly, a flow tube assembly, an upper valve body (2), and a pressure fluctuation suppression assembly. An air inlet, an air outlet and an air flow channel connecting the air inlet and the air outlet are arranged in the lower valve body (1); a throttle assembly for adjusting the degree of opening of the air flow channel in the lower valve body (1) is further disposed on the lower valve body (1). The flow tube assembly comprises a flow tube (3), an upper base (4), a lower base (5), and a float (6); a vent hole is provided on each of axial centers of the upper base (4) and the lower base (5); the lower base (5) is arranged at the air outlet of the lower valve body (1); a vertical air flow passage and a horizontal air flow passage are arranged in the upper valve body (2); the upper base (4) is arranged at an air inlet of the vertical air flow passage in the upper valve body (2); the flow tube (3) is disposed between the upper base (4) and the lower base (5) through two ends thereof that are respectively sleeved on protruding portions of the upper base (4) and the lower base (5); the float (6) is disposed in the flow tube (3). The pressure fluctuation suppression assembly comprises a sealing gasket (7), and the sealing gasket (7) is disposed at an air outlet of the vertical air flow passage.